艾司利卡西平 T3285L
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
1 mL | 104746-04-5 | ¥455.00 | 询底价 |
25 mg | 104746-04-5 | ¥1,230.00 | 询底价 |
1 mg | 104746-04-5 | ¥186.00 | 询底价 |
100 mg | 104746-04-5 | ¥2,880.00 | 询底价 |
10 mg | 104746-04-5 | ¥662.00 | 询底价 |
200 mg | 104746-04-5 | ¥4,180.00 | 询底价 |
2 mg | 104746-04-5 | ¥258.00 | 询底价 |
50 mg | 104746-04-5 | ¥1,880.00 | 询底价 |
5 mg | 104746-04-5 | ¥413.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Eslicarbazepine
描述: Eslicarbazepine (Stedesa) 是口服有效抗惊厥试剂,在局部癫痫的辅助研究中具有价值。
体外活性: Eslicarbazepine is an anti-epileptic drug, chemically related to carbamazepine but with a more favorable safety profile. Eslicarbazepine acetate is a prodrug for eslicarbazepine (S-licarbazepine), which is a dual Inhibitor of β-Secretase and voltage-gated sodium channel[1][2].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 12 mg/mL (47.19 mM)
关键字: Eslicarbazepine | Inhibitor | inhibit
相关产品: BACE1-IN-13 | Cassiaside | Sophoflavescenol | LY2811376 | AZD3839 free base | Se-Methylselenocysteine hydrochloride | Scoulerine | LX2343 | Verubecestat | Epiberberine chloride
相关库: Ion Channel Inhibitor Library | Drug Repurposing Compound Library | Anti-Neurodegenerative Disease Compound Library | Approved Drug Library | Anti-Cancer Compound Library | Anti-Cancer Drug Library | Clinical Compound Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | Anti-Cancer Approved Drug Library
艾司利卡西平 T3285L信息由TargetMol中国为您提供,如您想了解更多关于艾司利卡西平 T3285L报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途